Amended Statement of Ownership (sc 13g/a)
14 Fevereiro 2023 - 7:07PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G/A
Under the Securities
Exchange Act of 1934
(Amendment No. 2)*
PhaseBio
Pharmaceuticals, Inc.
(Name of Issuer)
Common Stock, par value
$0.001 per share
(Title of Class of
Securities)
717224109
(CUSIP Number)
___________December 31,
2022__________
(Date of Event Which Requires
Filing of this Statement)
Check the
appropriate box to designate the rule pursuant to which this Schedule is filed:
¨ Rule 13d-1(b)
x Rule 13d-1(c)
¨ Rule 13d-1(d)
*The remainder
of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information
required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of
the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. 717224109
| 1 |
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
RA Capital Management, L.P.
|
| 2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) ¨
(b) ¨
|
| 3 |
SEC USE ONLY
|
| 4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH: |
5 |
SOLE VOTING POWER
0
|
| 6 |
SHARED VOTING POWER
0
|
| 7 |
SOLE DISPOSITIVE POWER
0
|
| 8 |
SHARED DISPOSITIVE POWER
0
|
| 9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
|
| 10 |
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ¨
|
| 11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0%
|
| 12 |
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IA, PN
|
| |
|
|
|
CUSIP No. 717224109
| 1 |
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Peter Kolchinsky
|
| 2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) ¨
(b) ¨
|
| 3 |
SEC USE ONLY
|
| 4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH: |
5 |
SOLE VOTING POWER
0
|
| 6 |
SHARED VOTING POWER
0
|
| 7 |
SOLE DISPOSITIVE POWER
0
|
| 8 |
SHARED DISPOSITIVE POWER
0
|
| 9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
|
| 10 |
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ¨
|
| 11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0%
|
| 12 |
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
HC, IN
|
| |
|
|
|
CUSIP No. 717224109
| 1 |
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Rajeev Shah
|
| 2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) ¨
(b) ¨
|
| 3 |
SEC USE ONLY
|
| 4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH: |
5 |
SOLE VOTING POWER
0
|
| 6 |
SHARED VOTING POWER
0
|
| 7 |
SOLE DISPOSITIVE POWER
0
|
| 8 |
SHARED DISPOSITIVE POWER
0
|
| 9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
|
| 10 |
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ¨
|
| 11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0%
|
| 12 |
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
HC, IN
|
| |
|
|
|
CUSIP No. 717224109
| 1 |
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
RA Capital Healthcare Fund, L.P.
|
| 2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) ¨
(b) ¨
|
| 3 |
SEC USE ONLY
|
| 4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH: |
5 |
SOLE VOTING POWER
0
|
| 6 |
SHARED VOTING POWER
0
|
| 7 |
SOLE DISPOSITIVE POWER
0
|
| 8 |
SHARED DISPOSITIVE POWER
0
|
| 9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
|
| 10 |
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ¨
|
| 11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0%
|
| 12 |
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
|
| |
|
|
|
|
Item 1(a). |
Name of Issuer: |
PhaseBio Pharmaceuticals, Inc. (the
“Issuer”)
| Item 1(b). | Address
of Issuer’s Principal Executive Offices: |
1 Great Valley Parkway, Suite 30, Malvern, PA 19355
| Item 2(a). | Names
of Persons Filing: |
The names of the persons filing this report (collectively,
the “Reporting Persons”) are:
RA Capital Management, L.P. (“RA Capital”)
Peter Kolchinsky
Rajeev Shah
RA Capital Healthcare Fund, L.P. (the “Fund”)
| Item 2(b). | Address
of Principal Business Office or, if None, Residence: |
The address of the principal business office of each of
the Reporting Persons is:
c/o RA Capital Management, L.P., 200 Berkeley Street, 18th
Floor, Boston MA 02116
RA Capital and the Fund are Delaware limited partnerships.
Dr. Kolchinsky and Mr. Shah are United States citizens.
| Item 2(d). | Title
of Class of Securities: |
Common stock, par value $0.001 per share (“Common
Stock”)
717224109
| Item 3. | If
this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or
(c), check whether the person filing is a: |
Not applicable.
Provide the following information regarding the
aggregate number and percentage of the class of securities of the issuer identified in Item 1.
| (a) |
Amount Beneficially Owned:
See the response(s) to Item 9 on the attached cover page(s).
|
| (b) |
Percent of Class:
See the response(s) to Item 11 on the attached cover page(s). |
| |
|
| (c) |
Number of shares as to which such person
has: |
| |
|
| |
(i) |
sole power to vote or to direct the vote:
See the response(s) to Item 5 on the attached cover page(s). |
| |
|
|
| |
(ii) |
shared power to vote or to direct the vote
See the response(s) to Item 6 on the attached cover page(s). |
| |
|
|
| |
(iii) |
sole power to dispose or to direct the disposition of
See the response(s) to Item 7 on the attached cover page(s). |
| |
|
|
| |
(iv) |
shared power to dispose or to direct the disposition of
See the response(s) to Item 8 on the attached cover page(s). |
| Item 5. | Ownership
of Five Percent or Less of a Class. |
If
this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner
of more than five percent of the class of securities, check the following x.
| Item 6. | Ownership
of More than Five Percent on Behalf of Another Person. |
Not applicable.
| Item 7. | Identification
and Classification of the Subsidiary Which Acquired the Security Being Reported on by the
Parent Holding Company or Control Person. |
Not applicable.
| Item 8. | Identification
and Classification of Members of the Group. |
Not applicable.
| Item 9. | Notice
of Dissolution of Group. |
Not applicable.
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant
in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
Exhibit List
Exhibit 1: Joint Filing Agreement
SIGNATURE
After reasonable inquiry and to the best of its
knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.
| Date: February 14, 2023 |
|
| |
|
| |
|
|
| RA CAPITAL MANAGEMENT,
L.P. |
|
| |
|
|
| |
|
|
| By: |
/s/
Peter Kolchinsky |
|
| |
Name: |
Peter Kolchinsky |
|
| |
Title: |
Authorized Signatory |
|
| |
|
|
| PETER KOLCHINSKY |
|
| |
|
|
| /s/
Peter Kolchinsky |
|
| |
|
|
| RAJEEV SHAH |
|
| |
|
|
| /s/
Rajeev Shah |
|
| |
|
|
| |
|
|
| RA CAPITAL HEALTHCARE
FUND, L.P. |
|
| |
|
|
| By: |
RA Capital Healthcare
Fund GP, LLC |
|
| Its: |
General Partner |
|
| |
|
|
| By: |
/s/
Peter Kolchinsky |
|
| |
Name: |
Peter Kolchinsky |
|
| |
Title: |
Manager |
|
EXHIBIT 1
AGREEMENT
This Joint Filing Agreement, dated as of February 14, 2023, is
by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively
referred to herein as the “Filers”).
Each of the Filers may be required to file with the United States
Securities and Exchange Commission a statement on Schedule 13G and/or 13D with respect to Common Stock $0.001 par value per share of
PhaseBio Pharmaceuticals, Inc. beneficially owned by them from time to time.
Pursuant to and in accordance with Rule 13(d)(1)(k) promulgated
under the Securities Exchange Act of 1934, as amended, the Filers hereby agree to file a single statement on Schedule 13G and/or 13D
(and any amendments thereto) on behalf of each of such parties, and hereby further agree to file this Joint Filing Agreement as an exhibit
to such statement, as required by such rule.
This Joint Filing Agreement may be terminated by any of the Filers
upon one week’s prior written notice or such lesser period of notice as the Filers may mutually agree.
Executed and delivered as of the date first above written.
| RA CAPITAL MANAGEMENT, L.P. |
|
| |
|
|
| |
|
|
| By: |
/s/ Peter Kolchinsky |
|
| |
Name: |
Peter Kolchinsky |
|
| |
Title: |
Authorized Signatory |
|
| PETER KOLCHINSKY |
|
| |
|
|
| /s/ Peter Kolchinsky |
|
| |
|
|
| RAJEEV SHAH |
|
| |
|
|
| /s/ Rajeev Shah |
|
| |
|
|
| |
|
|
| RA CAPITAL HEALTHCARE FUND, L.P. |
|
| |
|
|
| By: |
RA Capital Healthcare Fund GP, LLC |
|
| Its: |
General Partner |
|
| |
|
|
| By: |
/s/ Peter Kolchinsky |
|
| |
Name: |
Peter Kolchinsky |
|
| |
Title: |
Manager |
|
PhaseBio Pharmaceuticals (CE) (USOTC:PHASQ)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025
PhaseBio Pharmaceuticals (CE) (USOTC:PHASQ)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025
